Pharmala Biotech Holdings Investor Relations Material
Latest events
Q1 2025
Pharmala Biotech Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pharmala Biotech Holdings Inc
Access all reports
Pharmala Biotech Holdings Inc is a biotechnology company focused on the research, development, and manufacturing of medical-grade psychedelic compounds. The company specializes in the production of MDMA and related substances for use in scientific research and potential therapeutic applications. Its activities include active pharmaceutical ingredient (API) synthesis, regulatory compliance, and supply to clinical trial sponsors and academic institutions. The company is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
MDMA
Country
🇨🇦 Canada